Centaur Pharmaceuticals, Inc.

Renovis, Inc.

William D Flitter

William A Garland

Allan L Wilcox

Richard E Paylor

Ian Irwin

Beverly Greenwood Van-Meerveld

Kirk R Maples

Helming Tan

A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.

Acetamidobenzamide compounds for neurodegenerative disorders

Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using aryl nitrone compounds. Pharmaceutical compositions containing aryl nitrone compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.

Aryl nitrone therapeutics and methods for treating inflammatory bowel disease

Disclosed are methods for treating or preventing inflammatory bowel disease (IBD) using amide and related compounds. Pharmaceutical compositions containing amide compounds which are useful for the treatment or prophylaxis of IBD are also disclosed.

Amide therapeutics and methods for treating inflammatory bowel disease

Amide therapeutics for the treatment of inflammatory bowel disease

Aryl nitrone therapeutics for the treatment of inflammatory bowel disease

Benzamides are disclosed to be useful for treating and preventing inflammatory bowel disease.

Benzamide therapeutics for the treatment of inflammatory bowel disease

A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease or Alzheimer's which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.

Benzamides for neurodegenerative disorder treatment

Pharmaceutical compositions of acetamidobenzamide compounds for

Pharmaceutical compositions of nitro- and aminobenzamide compounds for

Nitro- and aminobenzamide compounds for neurodegenerative disorders

Growing community of inventors

Mountain View, CA, United States of America

William D Flitter